01.01.2009 | Research Articles
Cost-effectiveness analysis of docetaxel (Taxotere®) vs. 5-fluorouracil in combined therapy in the initial phases of breast cancer
Erschienen in: Clinical and Translational Oncology | Ausgabe 1/2009
Einloggen, um Zugang zu erhalten